Sean Tiggelaar

We don’t have enough information about this author to calculate their statistics. If you think this is an error let us know.
Learn More
AIM Compare medication utilization, costs and healthcare resource use in schizophrenia patients with substance-related disorders initiated on once-monthly paliperidone palmitate (PP1M) or an oral(More)
OBJECTIVE The objective of this study was to compare persistence, costs, and healthcare resource utilization in patients with schizophrenia and cardiometabolic comorbidities treated with once-monthly(More)
  • 1